Gene · 5885
Papers3,897
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 3,897
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CRISPR-Cas9-based functional interrogation of unconventional translatome reveals human cancer dependency on cryptic non-canonical open reading frames. | Nat Struct Mol Biol | 2023 | 37932451 | PubTator, text mining | PubMed |
| Human tumor viruses: induction of three-dimensional alterations in the host genome structure. | Front Microbiol | 2023 | 37928671 | PubTator, text mining | PubMed |
| eRNA co-expression network uncovers TF dependency and convergent cooperativity. | Sci Rep | 2023 | 37925545 | PubTator, text mining | PubMed |
| Ultrafine mapping of chromosome conformation at hundred basepair resolution reveals regulatory genome architecture. | Proc Natl Acad Sci U S A | 2023 | 37922325 | PubTator, text mining | PubMed |
| The chromatin network helps prevent cancer-associated mutagenesis at transcription-replication conflicts. | Nat Commun | 2023 | 37898641 | PubTator, text mining | PubMed |
| The three-dimensional structure of the EBV genome plays a crucial role in regulating viral gene expression in EBVaGC. | Nucleic Acids Res | 2023 | 37889078 | PubTator, text mining | PubMed |
| A Small De Novo CNV Deletion of the Paternal Copy of FOXF1, Leaving lncRNA FENDRR Intact, Provides Insight into Their Bidirectional Promoter Region. | Noncoding RNA | 2023 | 37888207 | PubTator, text mining | PubMed |
| Bioinformatic Analysis of Recurrent Genomic Alterations and Corresponding Pathway Alterations in Ewing Sarcoma. | J Pers Med | 2023 | 37888109 | PubTator, text mining | PubMed |
| Understanding blood development and leukemia using sequencing-based technologies and human cell systems. | Front Mol Biosci | 2023 | 37886034 | PubTator, text mining | PubMed |
| Transforming Acute Myeloid Leukemia Treatment Through Next-Generation Sequencing: A Single-Center Experience. | Cureus | 2023 | 37885525 | PubTator, text mining | PubMed |
| Ceramide synthase 4 overexpression exerts oncogenic properties in breast cancer. | Lipids Health Dis | 2023 | 37885013 | PubTator, text mining | PubMed |
| Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer. | Clin Cancer Res | 2023 | 37870965 | PubTator, text mining | PubMed |
| Development of Computational Correlations among Known Drug Scaffolds and their Target-Specific Non-Coding RNA Scaffolds of Alzheimer's Disease. | Curr Alzheimer Res | 2023 | 37870052 | PubTator, text mining | PubMed |
| Primary clear cell carcinoma of the vulva: A case report. | Gynecol Oncol Rep | 2023 | 37860082 | PubTator, text mining | PubMed |
| Identification of CKS2 as a novel prognostic biomarker and potential therapeutic target for oral squamous cell carcinoma. | Transl Cancer Res | 2023 | 37859732 | PubTator, text mining | PubMed |
| Genomic instability and eye diseases. | Adv Ophthalmol Pract Res | 2023 | 37846358 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets. | EBioMedicine | 2023 | 37837931 | PubTator, text mining | PubMed |
| Transcriptome Analysis of Cisplatin, Cannabidiol, and Intermittent Serum Starvation Alone and in Various Combinations on Colorectal Cancer Cells. | Int J Mol Sci | 2023 | 37834191 | PubTator, text mining | PubMed |
| TOAST: A novel method for identifying topologically associated domains based on graph auto-encoders and clustering. | Comput Struct Biotechnol J | 2023 | 37822562 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5885/papers?page=16